The Files Crypto
1.3K posts

The Files Crypto
@TSoumillon29231
🚀 Crypto enthusiast | 🌐 Exploring Web3 | 📚 Always learning


JUST IN: Moderna announces it’s working on a hantavirus vaccine.


🦠 SOUTH KOREA AND CHINA LEAD GLOBAL HANTAVIRUS VACCINE DEVELOPMENT The most advanced hantavirus vaccines are currently available in South Korea and China. South Korea has used the Hantavax vaccine from Green Cross Corporation for decades, targeting the Hantaan virus (HTNV), which causes hemorrhagic fever with renal syndrome (HFRS). A Phase III trial completed in 2020 confirmed its safety and immunogenicity, although long-term protection weakens over time, limiting its use mainly to high-risk groups. China also uses several inactivated vaccines against HTNV and Seoul virus, with millions of administered doses contributing to a major decline in HFRS cases. No hantavirus vaccine has yet been approved in Europe or the United States. The leading Western candidates are DNA vaccines developed by USAMRIID/WRAIR against Hantaan and Puumala viruses, currently in Phase II testing. In the UK, the MVA-Hanta candidate based on a Modified Vaccinia Ankara vector remains in Phase I trials. Development is progressing slowly because hantaviruses are not considered a top global priority compared with diseases such as COVID-19 or influenza. There is still no approved vaccine for European or American strains including Puumala, Sin Nombre or Andes virus. app.moodix.market/article/1740

Since Hantavirus is gaining attention, here is a list of Korean stocks linked to Hantavax (Hantavirus vaccine): • GENEONE Life Science • GC (Green Cross) • JoongAng Vaccine • Woojin B&G • Komipharm • Eagle Vet • CHESIS Not financial advice.




























